Clinical Professor, Dept. of Ophthalmology & Visual Sciences
Biography

Dr. Patrick Ma is a clinical professor at the UBC Department of Ophthalmology since 1994 and current Head of the UBC Retina Division. Initially trained as an optometrist, Dr. Ma completed his residency in Ophthalmology in Ottawa and completed sub-specialty retinal fellowship in New Orleans. Professional associations include past-president of BC Society of Eye Physicians and Surgeons, Chair of the UBC Tele-ophthalmology program, Operating Room Steering Committee and with ORBIS International travelling to China, Bangladesh and Vietnam.

Dr. Ma has expertise and performs research in the medical and surgical management of diabetic retinopathy, age-related macular degeneration, pathologic myopia, retinal vein occlusions, uveitis, paediatric vitreo-retinal diseases and complex retinal detachments. Dr. Ma is currently involved as a principal investigator and co-investigator for multiple industry sponsored clinical trials as well as investigator driven pilot studies. Dr. Ma also supervises numerous medical students and residents for the Department of Ophthalmology’s Annual Research Day as well as publications for a variety of medical journals.

Recent Publications

  1. COMPARISON OF PHOTODYNAMIC THERAPY AND TRANSPUPILLARY THERMOTHERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION   DAVID A. L. MABERLEY, MD, FRCSC, HALL CHEW MD, PATRICK MA MD, FRCSC, ANGELA CHANG BSc, HUSSEIN HOLLANDS MSc, ALAN MABERLEY MD FRCSC CJO JCO JUNE 2005
  2. STAGE SPECIFICITY OF NOVEL GROWTH FACTOR EXPRESSION DURING DEVELOPMENT OF PROLIFERATIVE VITREORETINOPATHY   CLINICAL STUDY JZ CHIU, D. MABERLEY,   P. MA   A. SAMAD, JA MATSUBARA    EYE (2006) 1-9
  3. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. Zandieh I MD, ADENWALLA M MD, MA P. E. MD, CHEONG-LEE C MD, YOSHIDA EM MD.   (Aug 14, 2006 WORLD J. Gastroenterol)
  4. EXPRESSION OF INTEGRINS IN HUMAN PROLIFERATIVE DIABETIC RETINOPATHY MEMBRANES (aLLISON NING, BSC; JING CUI, MD; DAVID MABERLEY, MD; PATRICK E. MA, MD; JOANNE MATSUBARA, PHD0 – CAN J OPHTHALMOLOGY – VOL. 43 NO. 6, 2008
  5. EXPRESSION OF INTEGRINS ON HUMAN CHOROIDAL NEOVASCULAR MEMBRANES (JING CUI, MD; DAVID MABERLEY, MD; PATRICK E. MA, MD; JOANNE MATSUBARA, PHDO; PETER BACIU – HUMAN PRESS 2009 2-12-19)
  6. The effects of intravitreal vevacizumab on patients with macular edema secondary to branch retinal vein occlusion.   Ahmadi AA, Chuo J, Banashkevich A, Ma P, Maberley D. Can J Ophthalmol 2009;44:154-159.
  7. Ranibizumab is a potential prophylaxis for PVR (proliferative vitreoretinopathy), a non-angiogenic blinding disease Steven Pennock, David Kim, Shizuo Mukai, Matthew Kuhnle, Dal W. Chun, Joanne A. Matsubara, Jing Cui, Patrick Ma, David Maberley, Arif Samad, R.J. van Geest, Andrius Kazlauskas – (2012 unpublished)